Research ArticleExperimental Studies

Pretreatment with S-1, an Oral Derivative of 5-Fluorouracil, Enhances Gemcitabine Effects in Pancreatic Cancer Xenografts

SHIN NAKAHIRA, SHOJI NAKAMORI, MASANORI TSUJIE, SETSUO TAKEDA, KEISHI SUGIMOTO, YUJI TAKAHASHI, JIRO OKAMI, SHIGERU MARUBASHI, ATSUSHI MIYAMOTO, YUTAKA TAKEDA, HIROAKI NAGANO, KEIZO DONO, KOJI UMESHITA, MASATO SAKON and MORITO MONDEN
Anticancer Research January 2008, 28 (1A) 179-186;

Article Information

vol. 28 no. 1A 179-186
PubMed 
18383843
Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received June 15, 2007
  • Revision received November 26, 2007
  • Accepted December 17, 2007
  • Published online January 1, 2008.
Copyright & Usage 
Copyright© 2008 International Institute of Anticaner Research (Dr. John G. Delinassios), All rights reserved

Author Information

  1. SHIN NAKAHIRA1,2,
  2. SHOJI NAKAMORI1,3,
  3. MASANORI TSUJIE1,3,
  4. SETSUO TAKEDA1,
  5. KEISHI SUGIMOTO2,
  6. YUJI TAKAHASHI1,
  7. JIRO OKAMI1,
  8. SHIGERU MARUBASHI1,
  9. ATSUSHI MIYAMOTO1,
  10. YUTAKA TAKEDA1,
  11. HIROAKI NAGANO1,
  12. KEIZO DONO1,
  13. KOJI UMESHITA1,
  14. MASATO SAKON1 and
  15. MORITO MONDEN1
  1. 1Department of Surgery and Clinical Oncology, Graduate School of Medicine, Osaka University, E2, 2-2 Yamadaoka, Suita, Osaka 565-0871
  2. 2Department of Surgery, Kansai Rosai Hospital, 3-1-69, Inabaso, Amagasaki, Hyogo 660-8511
  3. 3Department of Surgery, Osaka National Hospital, National Hospital Organization, 2-1-14 Hoenzaka, Chuo-ku, Osaka 540-0006, Japan
  1. Correspondence to: Shoji Nakamori, MD, Ph.D., Chief Surgeon of Department of Surgery, Cancer Center, Head of Molecular Medicine, Osaka National Hospital, National Hospital Organization, 2-1-14 Hoenzaka, Chuo-ku, Osaka 540-0006, Japan. Tel: +81669421331, Fax: +81669436467, e-mail: nakamori{at}onh.go.jp

Statistics from Altmetric.com

Cited By...

Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools
Reprints and Permissions
Pretreatment with S-1, an Oral Derivative of 5-Fluorouracil, Enhances Gemcitabine Effects in Pancreatic Cancer Xenografts
SHIN NAKAHIRA, SHOJI NAKAMORI, MASANORI TSUJIE, SETSUO TAKEDA, KEISHI SUGIMOTO, YUJI TAKAHASHI, JIRO OKAMI, SHIGERU MARUBASHI, ATSUSHI MIYAMOTO, YUTAKA TAKEDA, HIROAKI NAGANO, KEIZO DONO, KOJI UMESHITA, MASATO SAKON, MORITO MONDEN
Anticancer Research Jan 2008, 28 (1A) 179-186;
Twitter logo Facebook logo Mendeley logo

Jump to section